Cargando…

Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome

Factor V Leiden (FVL) G1619A mutation and prothrombin gene (PTG) G20210A are the most common inherited thrombophilias. They have been associated with various obstetric complications such as venous thromboembolism, recurrent pregnancy loss, preeclampsia, abruptio placentae, and small for gestational...

Descripción completa

Detalles Bibliográficos
Autores principales: Padda, Jaskamal, Khalid, Khizer, Mohan, Ayushi, Pokhriyal, Sindhu, Batra, Nitya, Hitawala, Gazala, Cooper, Ayden Charlene, Jean-Charles, Gutteridge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439407/
https://www.ncbi.nlm.nih.gov/pubmed/34540419
http://dx.doi.org/10.7759/cureus.17185
_version_ 1783752519460061184
author Padda, Jaskamal
Khalid, Khizer
Mohan, Ayushi
Pokhriyal, Sindhu
Batra, Nitya
Hitawala, Gazala
Cooper, Ayden Charlene
Jean-Charles, Gutteridge
author_facet Padda, Jaskamal
Khalid, Khizer
Mohan, Ayushi
Pokhriyal, Sindhu
Batra, Nitya
Hitawala, Gazala
Cooper, Ayden Charlene
Jean-Charles, Gutteridge
author_sort Padda, Jaskamal
collection PubMed
description Factor V Leiden (FVL) G1619A mutation and prothrombin gene (PTG) G20210A are the most common inherited thrombophilias. They have been associated with various obstetric complications such as venous thromboembolism, recurrent pregnancy loss, preeclampsia, abruptio placentae, and small for gestational age fetus. The prevalence of these two mutations is 3-15% in Caucasians and is assumed to be far less common in other ethnic populations. However, there have been several controversies regarding advising routine screening of these thrombophilias because of a widely variable strength of association between different ethnic groups, as well as contradictory conclusions by different studies in regards to the association. In this study, the literature was analyzed thoroughly for the effect of FVL G1619A and PTG G20210A mutations on various obstetric outcomes. A review of multiple case-control and prospective studies suggests that despite the availability of robust data on this subject the results remain inconclusive and insubstantial. Further superior quality research, preferably prospective studies, is warranted to conclusively establish this relationship and to enable practitioners to follow a definitive protocol in the screening of various populations for these mutations to achieve an improved pregnancy outcome.
format Online
Article
Text
id pubmed-8439407
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-84394072021-09-16 Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome Padda, Jaskamal Khalid, Khizer Mohan, Ayushi Pokhriyal, Sindhu Batra, Nitya Hitawala, Gazala Cooper, Ayden Charlene Jean-Charles, Gutteridge Cureus Internal Medicine Factor V Leiden (FVL) G1619A mutation and prothrombin gene (PTG) G20210A are the most common inherited thrombophilias. They have been associated with various obstetric complications such as venous thromboembolism, recurrent pregnancy loss, preeclampsia, abruptio placentae, and small for gestational age fetus. The prevalence of these two mutations is 3-15% in Caucasians and is assumed to be far less common in other ethnic populations. However, there have been several controversies regarding advising routine screening of these thrombophilias because of a widely variable strength of association between different ethnic groups, as well as contradictory conclusions by different studies in regards to the association. In this study, the literature was analyzed thoroughly for the effect of FVL G1619A and PTG G20210A mutations on various obstetric outcomes. A review of multiple case-control and prospective studies suggests that despite the availability of robust data on this subject the results remain inconclusive and insubstantial. Further superior quality research, preferably prospective studies, is warranted to conclusively establish this relationship and to enable practitioners to follow a definitive protocol in the screening of various populations for these mutations to achieve an improved pregnancy outcome. Cureus 2021-08-15 /pmc/articles/PMC8439407/ /pubmed/34540419 http://dx.doi.org/10.7759/cureus.17185 Text en Copyright © 2021, Padda et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Padda, Jaskamal
Khalid, Khizer
Mohan, Ayushi
Pokhriyal, Sindhu
Batra, Nitya
Hitawala, Gazala
Cooper, Ayden Charlene
Jean-Charles, Gutteridge
Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
title Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
title_full Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
title_fullStr Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
title_full_unstemmed Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
title_short Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
title_sort factor v leiden g1691a and prothrombin gene g20210a mutations on pregnancy outcome
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439407/
https://www.ncbi.nlm.nih.gov/pubmed/34540419
http://dx.doi.org/10.7759/cureus.17185
work_keys_str_mv AT paddajaskamal factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome
AT khalidkhizer factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome
AT mohanayushi factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome
AT pokhriyalsindhu factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome
AT batranitya factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome
AT hitawalagazala factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome
AT cooperaydencharlene factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome
AT jeancharlesgutteridge factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome